Top StoriesStory: Compound Can Hasten Harvest of Stem Cells Article Story: NIGMS Funds New Stem Cell Centers Article ScienceReprogramming Complicates Stem Cell Debate: Technique Could Revolutionize Therapies Scientists are working to develop new techniques that may one day allow the body to produce fresh cells to heal itself. Article Repair for Frail Immune Systems Researchers have discovered a way to improve the immune system that could help donor organ recipients and people with cancer and AIDS fight deadly diseases. Article Bringing Safe and Effective Cell Therapies to the Bedside New rules to assess the safety and efficacy of human cell- and tissue-based products are the culmination of a multiyear, cooperative effort between the US government and the biotech industry. Article Tumour Defence System Boosts Immunotherapeutic R&D The researchers, from the Torrey Pines Institute for Molecular Studies in San Diego, discovered that tumours secrete fatty acids, which inhibit the cytotoxic T lymphocytes’ ability to kill tumour cells. Article Gene Therapy to Treat Haemophilia Gene therapy has been used to successfully treat haemophilia in dogs. Article GMP Materials Ready for Cervical Cancer Trial Advaxis announced that its GMP clinical materials have passed quality control release and are available for use in a Phase I/II clinical trial of Lovaxin C in advance cervical cancer patients. Article Canadian Stem Cell Star Shuns US Riches A leading stem-cell scientist has turned down a multimillion-dollar offer in the United States in favour of heading Canada’s first stem-cell research centre. Article ABSTRACT, REVIEWS, & SPECIAL REPORTS Design and Creation of Cytomedicine for Application to Cell Therapy Abstract Endobronchial Gene Therapy Abstract New Agents for the Prevention of Opportunistic Infections in Haematopoietic Stem Cell Transplant Recipients Abstract BusinessBUSINESS NEWS Tissera Reports the Company’s Scientific Team Has Reached Significant Milestones in its Research on Pig Fetal Liver Transplantation Tissera, Inc. reports that Tissera’s sponsored research team at the Weizmann Institute of Science has reached significant milestones in its research on xenotransplantation of pig fetal liver. Article THP Generates Transgenic Rabbits Producing Human Antibodies Therapeutic Human Polyclonals Inc. (THP) has created the first transgenic rabbits producing human antibodies. THP is now applying this technology to the development of its first products and clinical trials. Article Mount Sinai Receives NIH Funding for Stem Cell Research The National Institute of General Medicine Sciences (NIGMS) announced today that Mount Sinai School of Medicine and two other centers will receive an estimated $9 million dollar grant over the next three years to further stem cell research. Article Cytori Therapeutics, Inc. Completes Development Of The Celution(TM) System; To Submit CE Mark Application For European Approval Cytori Therapeutics, Inc., today announced it has completed the development of its Celution(TM) System for the isolation and concentration of adipose stem cells and will submit CE Mark application seeking approval for the system in Europe. Article Michael Monko Named Vice President Sales, Serologicals Corporation Research Products Group Serologicals Corporation announced today that Michael Monko has joined the Company as Vice President, Sales for the Research Products Segment, consisting of Chemicon International, Inc. and the Upstate Group, Inc. Mr. Monko will report directly to Jeffrey D. Linton, President and will be a member of Research Segment Executive Operating Committee. Article MARKET REPORTS Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer. “Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide. For more information, including order forms, please see: Cell Therapy Report Summary Cell Therapy Sample Chapter Cell Therapy Table of Contents Vol. 1 Vol. 2 Cell Therapy Order Form “Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide. For more information, including order forms, please see: Gene Therapy Report Summary Gene Therapy Table of Contents Vol. 1 Vol. 2 Gene Therapy Order Form The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer. A Shift in Cancer Immunotherapy Strategies? Immunotherapy Strategies Executive Summary Immunotherapy Strategies Table of Contents Future Perspectives in Cancer Immunotherapy Future Perspectives Executive Summary Future Perspectives Table of Contents NIHNATIONAL INSTITUTES OF HEALTH NIH Guide for Grants and Contracts – Week Of August 12, 2005 Link Short Courses on Application of Genomics and Proteomics to Complex Heart, Lung, Blood, and Sleep Disorders (RFA-HL-05-012) Application Receipt Date(s): January 17, 2006 Link CBERAll new CBER information can be reached from the What’s New page2005 Biological Approvals – Update Link Approval Information – Blood Grouping Reagent, Anti-A (Murine Monoclonal); Anti-B (Murine Monoclonal); Anti-A,B (Murine Monoclonal Blend); Anti-D (Monoclonal) (IgM) – Biotest AG Link Approval Information – Anti-Human Globulin, Anti-IgG (Rabbit) – Biotest AG Link Approval Information – Reagent Red Blood Cells – Medion Diagnostics GmbH Link Substantially Equivalent 510(k) Device – Tango Automated Blood Bank Analyzer System – Olympus America Inc Link Licensed Products and Establishments List – Update Link Substantially Equivalent 510(k) Device – GPS II Platelet Concentrate Separation Kit w/ Plasma Concentrator Accesory – Biomet, Inc Link RegulatoryFor Country-Specific & International Regulatory Resources, Including Regulatory Agencies Such As the FDA, EMEA, & More, Please Visit The Regulatory Page On The Cell Therapy News Website Meetings
Contact Malachite Management if your company is interested in hosting an educational symposium at a future conference. Upcoming symposia opportunities include: – World Transplant Congress (WTC). July 22-27, 2006. Boston, MA. Symposia dates: July 20, 21 or 28. Application Deadline: September 11, 2005 – Canadian Blood & Marrow Transplant Group (CBMTG) Biennial Conference. April 22-24, 2006. Edmonton, AB. Symposia dates: April 22. Application Deadline: January 2006. – American Society for Apheresis (ASFA) Annual Conference. May 23-26, 2006. Las Vegas, NV. Symposia date: May 23. Application Deadline: March 15, 2005. – International Society for Cellular Therapy (ISCT) Annual Conference. May 4-7, 2006. Berlin, Germany. Symposia dates: May 4, 5, or 7. Application Deadline: January 2006. – American Society for Hematology (ASH) December 9-12, 2006. Orlando, FL. Symposia date: December 8. Application Deadline: early April 2006 FEATURED MEETINGS Emerging Cardiac Cellular Therapies: Incorporating cGMP Federal Regulations into Clinical Trials. Bethesda, MD Co-sponsored by AABB and ISCT September 15 – 16, 2005 This year, a Cardiac Cell Therapy Workshop has been created to precede the annual Somatic Cell Therapy Symposium. This workshop was designed to address questions related to the various cell types being used in the context of cardiac repair. Link Fifth Annual Somatic Cell Therapy Symposium. Bethesda, MD Co-sponsored by AABB, ISCT and FDA September 16 – 18, 2005 The annual Somatic Cell Therapy Symposium is a forum provided to engage FDA and industry in an ongoing dialogue regarding the regulatory issues pertaining to somatic and other cell therapies. Link
To View an Up-to-Date List of Cell Therapy-Related Meetings, Please Visit The Meetings Page On The Cell Therapy News Website JournalsTo View a List of Cell Therapy-Related Journals, Please Visit The Journals Page On The Cell Therapy News Website CareersJOB POSTINGS IN CELL THERAPY NEWS ARE FREE! For information on posting an opportunity email: info@connexoncreative.com Acting President San Diego, California (California Institute of Regenerative Medicine) Cell Therapy Supervisor New York, New York (New York Blood Center) Cell Therapy Technologist New York, New York (New York Blood Center) Cellular Production Lead Technician Seattle, Washington (Fred Hutchinson Cancer Research Center) Clinical Laboratory Scientist Los Angeles, California (Cedars-Sinai Medical Center) Clinical Consultant Deerfield, Illinois (Baxter Healthcare) Consultant– (AABB) Director of Cell Therapy New York, New York (New York Blood Center) Director of Research Programs Toronto, Ontario (Ontario Genomics Institute) Instrumentation Engineer II Gaithersburg, Maryland (Maxcyte) Laboratory Supervisor (Stem Cell Lab) Charlottesville, Virginia (University of Virginia Health System) Manager, Device Engineering Gaithersburg, Maryland (Maxcyte) Manager, Quality Assurance Gaithersburg, Maryland (Maxcyte) Marketing Manager Denver, Colorado (Gambro BCT) Medical Laboratory Technologist (Stem Cell) Roswell Park Cancer Institute (Buffalo, New York) Program Leader: Cell Biology (Professor/Associate Professor) Melbourne, Australia (Peter MacCallum Cancer Centre) Research Associate II Gaithersburg, Maryland (Maxcyte) Scientific Review & Program Officers San Diego, California (California Institute of Regenerative Medicine) Scientific Sales Representative Vancouver, British Columbia (StemCell Technologies) Scientific/Technical Officer,Stem Cell Transplant Laboratory/Haematology Sydney, Australia (SWAPS, Liverpool Hospital) Senior Hospital Scientist Sydney, Australia (Australian Stem Cell Facility Sydney Children’s Hospital) Senior Officer for Medical & Ethical Standards San Diego, California (California Institute of Regenerative Medicine) Stem Cell Lab Lead Technologist Boston, Massachusetts (Beth Israel Deaconess Medical Center) Stem Cell Specialist Philadelphia, PennsylvaniaA (Children’s Hospital of Philadelphia) Supervising Medical Laboratory Technologist (Quality Assurance) Buffalo, New York (Roswell Park Cancer Institute) Supervising Medical Laboratory Technologist (HLA, Stem Cell, Therapeutic Apheresis) Buffalo, New York (Roswell Park Cancer Institute)
Therapy Scientist (Therapeutic Aphaeresis and Cell Therapy) Denver, Colorado (Gambro BCT) Profiled Journal Cytotherapy now incorporates “Cytokines, Cellular & Molecular Theory”Join ISCT ($130) and receive the journal as a benefit of membership http://www.celltherapy.org/mem_app.htmCurrent Volume: Volume 7, Number 3/ July 2005 Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy. www.cytotherapy.com
|
|
|